S100 deficiency is associated with early cessation of tumor growth in vivo and this is thought to be due to reduced recruitment of tumor-promoting macrophages to the tumor site (127). This evidence concerns the gene S100B and hyperinsulinemic hypoglycemia, familial, 4.